SCHEMBL14802408

SCHEMBL14802408

COc1ccc(C(=O)Nc2cc(N)ccc2-c2ccc(N)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.58
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 2/20 0.58
HPGD P15428 2/20 0.58
F10 P00742 2/20 0.56
HDAC1 Q13547 4/20 0.56
HDAC2 Q92769 3/20 0.56
HDAC8 Q9BY41 3/20 0.56
HDAC6 Q9UBN7 3/20 0.56
HDAC3 O15379 2/20 0.56
HDAC4 P56524 2/20 0.56
HDAC7 Q8WUI4 2/20 0.56
HDAC10 Q969S8 2/20 0.56
HDAC11 Q96DB2 2/20 0.56
HDAC9 Q9UKV0 2/20 0.56
HDAC5 Q9UQL6 2/20 0.56
GAA P10253 5/20 0.53
TP53 P04637 3/20 0.53
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14802419 0.94 NPC1 (0.56) MAPTALDH1A1KDM4EHPGDF10
SCHEMBL3790093 0.84 ALDH1A1 (0.47) MAPTALDH1A1KDM4EHPGDHDAC2
SCHEMBL24791968 0.82 HDAC1 (0.60) MAPTALDH1A1HDAC1HDAC2HDAC3
SCHEMBL14817822 0.80 NPC1 (0.58) MAPTALDH1A1KDM4EHPGDF10
SCHEMBL14802407 0.78 MAPT (0.66) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL10605968 0.77 GAA (0.66) MAPTALDH1A1KDM4EHDAC1HDAC8
SCHEMBL6816201 0.77 RAB9A (0.83) MAPTALDH1A1KDM4EHDAC1HDAC2
SCHEMBL11462217 0.77 RAB9A (0.83) MAPTALDH1A1KDM4EHDAC1HDAC2
SCHEMBL3784057 0.77 GAA (0.55) ALDH1A1KDM4EHPGDHDAC1HDAC2
SCHEMBL12933399 0.77 HDAC2 (0.87) MAPTALDH1A1KDM4EHPGDF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220401590-A1 COMPOUND OR SALT THEREOF SHIZUOKA PREFECTURAL UNIVERSITY CORPORATION (JP) 2022-12-22 US disclosed
US-9035057-B2 Dihydroethidine analogues and uses thereof WASHINGTON UNIVERSITY (US) 2015-05-19 US disclosed
US-9035057-B2 Dihydroethidine analogues and uses thereof WASHINGTON UNIVERSITY (US) 2015-05-19 US disclosed
US-20130079522-A1 DIHYDROETHIDINE ANALOGUES AND USES THEREOF WASHINGTON UNIVERSITY (US) 2013-03-28 US disclosed
US-20130079522-A1 DIHYDROETHIDINE ANALOGUES AND USES THEREOF WASHINGTON UNIVERSITY (US) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079522-A1 DIHYDROETHIDINE ANALOGUES AND USES THEREOF NOX4, QDPR, ROS1 MAPT 2035/4885ALDH1A1 114/4885KDM4E 2642/4885
US-20220401590-A1 COMPOUND OR SALT THEREOF NR3C2, NR3C1, NR1H3 MAPT 3926/4885ALDH1A1 2164/4885KDM4E 1936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.